13643 Improvement in specific locations, quality of life, and pruritus after 24 weeks of apremilast in bio-naïve moderate plaque psoriasis patients who failed to achieve a PASI-75 response: Interim results of a real-world prospective study in Greece (APRAISAL) - 28/11/20
Doi : 10.1016/j.jaad.2020.06.129
Dimitrios Ioannides, PhD
1st University Department of Dermatology, Aristotle University of Thessaloniki, Hospital for Venereal and Skin Diseases, Thessaloniki, Greece
Panagakis Pantelis, Pantelis Panagakis, Andreas Syggros, Eleftheria Tampouratzi, MD, Alexandros Drosos, MD
Tzaneio General Hospital, Piraeus, Greece
Rigopoulos Dimitris, Dimitris Rigopoulos, Christina Antoniou, MD, PhD
Medical School, National and Kapodistrian University, Athens
Ioannis Bassukas, MD, PhD
Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina
El texto completo de este artículo está disponible en PDF.
| Commercial disclosure: This presentation and associated research was sponsored by Celgene. |
© 2020
Publicado por Elsevier Masson SAS.
Vol 83 - N° 6S
P. AB10 - décembre 2020 Regresar al número
Artículo precedente
- 13640 A case of multiple aggressive granular cell tumors
- Leah Cohen, James Sun, Lucia Seminario-Vidal
- 13660 Role of oxidative stress and mitochondrial dysfunction in the pathogenesis of vitiligo
- Amanda Kuan, Sai Yee Chuah, Yun Sheng Yip, Nguan Soon Tan, Tien Guan Steven Thng
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?